1. Home
  2. RBC vs EXAS Comparison

RBC vs EXAS Comparison

Compare RBC & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RBC Bearings Incorporated

RBC

RBC Bearings Incorporated

HOLD

Current Price

$442.80

Market Cap

12.6B

Sector

Industrials

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.24

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBC
EXAS
Founded
1919
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.6B
11.0B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
RBC
EXAS
Price
$442.80
$101.24
Analyst Decision
Buy
Buy
Analyst Count
6
20
Target Price
$441.17
$76.38
AVG Volume (30 Days)
163.2K
9.8M
Earning Date
10-31-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
19.54
N/A
EPS
8.20
N/A
Revenue
$1,723,400,000.00
$3,082,033,000.00
Revenue This Year
$14.28
$16.68
Revenue Next Year
$10.86
$12.36
P/E Ratio
$53.86
N/A
Revenue Growth
8.27
14.47
52 Week Low
$290.56
$38.81
52 Week High
$449.60
$101.87

Technical Indicators

Market Signals
Indicator
RBC
EXAS
Relative Strength Index (RSI) 64.88 90.52
Support Level $418.05 $101.01
Resistance Level $449.60 $101.61
Average True Range (ATR) 11.10 2.63
MACD -0.33 1.94
Stochastic Oscillator 79.68 98.21

Price Performance

Historical Comparison
RBC
EXAS

About RBC RBC Bearings Incorporated

RBC Bearings Inc is an international manufacturer and marketer of engineered precision bearings, components, and essential systems for the industrial, defense, and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The company has two reportable segments: Industrial, which derives maximum revenue, and Aerospace/Defense. The Aerospace/Defense segment represents the end markets for the company's engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and the Industrial segment represents the end markets for its products used in various industrial applications. Geographically, the company generates a majority of its revenue from the United States.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: